semaglutide being taken off market Semaglutide: Half of Users Stop Drug Within Year in 'Concerning' Drop FDA ends semaglutide shortage, closing

107,108 Although the pancreatic beta-cells are the well-characterised target for GLP-1, the incretin hormone also targets multiple other organs

The FDA approved it on April 1, 2026, for adults with obesity or adults who are overweight and have at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes

Microdosing GLP-1 RAs is an off-label application of agents FDA-approved for Type 2 diabetes and/or obesity

GLP-1 stands for glucagon-like peptide-1 , a hormone naturally produced in your gut after eating

When youre vitamin B12 deficient, it can lead to various symptoms including fatigue, weakness, shortness of breath, heart palpitations, and more

Topical hyaluronic acid typically doesn't penetrate deeply enough to cause systemic effects like bloating